Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity, JAMA, 21 Oct 2021
The SARS-CoV-2 serology tests that eventually received FDA Emergency Use Authorization (EUA) have demonstrated high sensitivity and specificity, but that accuracy is for detecting antibodies. Their ability to predict protection against the virus based on those antibodies hasn't been proven. Plus, the FDA cautioned that some tests detect antibodies the immune system likely produces only after natural infection with the virus. Depending on the assay, people who weren't previously infected could test negative for antibodies despite having vaccine-induced immunity.

Therefore, the agency in its May 19 communication stated that "results from currently authorized SARS-CoV-2 antibody tests should not be used to evaluate a person's level of immunity or protection from COVID-19 at any time, and especially after the person received a COVID-19 vaccination."


FDA finds 3 COVID-19 tests that fail to detect the omicron variant, 16 Dec 2021
The agency on Wednesday updated its list of tests impacted by virus mutations. While FDA continues to gather additional information and work with the three manufacturers to address these issues, it recommended the diagnostics not be used by clinical laboratory staff and healthcare providers.
by Cat on Tue Dec 21st, 2021 at 06:50:15 PM EST

Others have rated this comment as follows:

Oui 4

Display:

Occasional Series